Lsv Asset Management Exelixis, Inc. Transaction History
Lsv Asset Management
- $45.6 Billion
- Q2 2024
A detailed history of Lsv Asset Management transactions in Exelixis, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 5,763,728 shares of EXEL stock, worth $155 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
5,763,728
Previous 2,774,707
107.72%
Holding current value
$155 Million
Previous $65.8 Million
96.69%
% of portfolio
0.28%
Previous 0.14%
Shares
12 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$899 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$796 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$727 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$407 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$338 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.63B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...